189 related articles for article (PubMed ID: 7710932)
1. The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
Woods JA; Hadfield JA; Pettit GR; Fox BW; McGown AT
Br J Cancer; 1995 Apr; 71(4):705-11. PubMed ID: 7710932
[TBL] [Abstract][Full Text] [Related]
2. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
[TBL] [Abstract][Full Text] [Related]
4. Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.
Lawrence NJ; Rennison D; Woo M; McGown AT; Hadfield JA
Bioorg Med Chem Lett; 2001 Jan; 11(1):51-4. PubMed ID: 11140732
[TBL] [Abstract][Full Text] [Related]
5. Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents.
Song MY; He QR; Wang YL; Wang HR; Jiang TC; Tang JJ; Gao JM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155790
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
Aleksandrzak K; McGown AT; Hadfield JA
Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
Kaffy J; Pontikis R; Florent JC; Monneret C
Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
[TBL] [Abstract][Full Text] [Related]
8. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
9. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
10. Tubulin-interactive stilbene derivatives as anticancer agents.
Mikstacka R; Stefański T; Różański J
Cell Mol Biol Lett; 2013 Sep; 18(3):368-97. PubMed ID: 23818224
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.
Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T
Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
13. Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.
McGown AT; Fox BW
Anticancer Drug Des; 1989 Mar; 3(4):249-54. PubMed ID: 2930627
[TBL] [Abstract][Full Text] [Related]
14. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.
Cao TM; Durrant D; Tripathi A; Liu J; Tsai S; Kellogg GE; Simoni D; Lee RM
Am J Hematol; 2008 May; 83(5):390-7. PubMed ID: 18175355
[TBL] [Abstract][Full Text] [Related]
15. The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
Greene LM; Nathwani SM; Bright SA; Fayne D; Croke A; Gagliardi M; McElligott AM; O'Connor L; Carr M; Keely NO; O'Boyle NM; Carroll P; Sarkadi B; Conneally E; Lloyd DG; Lawler M; Meegan MJ; Zisterer DM
J Pharmacol Exp Ther; 2010 Nov; 335(2):302-13. PubMed ID: 20699436
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
17. Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.
Pettit GR; Singh SB; Niven ML; Hamel E; Schmidt JM
J Nat Prod; 1987; 50(1):119-31. PubMed ID: 3598594
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.
Pandit B; Sun Y; Chen P; Sackett DL; Hu Z; Rich W; Li C; Lewis A; Schaefer K; Li PK
Bioorg Med Chem; 2006 Oct; 14(19):6492-501. PubMed ID: 16860559
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4.
Guan Q; Yang F; Guo D; Xu J; Jiang M; Liu C; Bao K; Wu Y; Zhang W
Eur J Med Chem; 2014 Nov; 87():1-9. PubMed ID: 25233100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
